{"id":"2021101835","sourceId":"marketwatch","sourceName":"MarketWatch","providerName":"Dow Jones","title":"Valneva shares jump 30% after saying vaccine candidate outperformed AstraZeneca's","publishedDate":"2021-10-18T03:14:00-05:00","body":[{"type":"p","contentObject":[{"type":"text","content":"\n  Valneva  shares jumped 30% in Paris trading after saying its coronavirus vaccine candidate outperformed AstraZeneca's  in a Phase 3 study, which met both its co-primary endpoints. Valneva said its vaccine had a neutralizing antibody seroconversion rate above 95% and that it had a better tolerability profile. ","gated":false}],"gated":false},{"type":"text","content":"\n","gated":false},{"type":"p","contentObject":[{"type":"text","content":"\n  -Steve Goldstein ","gated":false}],"gated":false},{"type":"text","content":"\n","gated":false},{"type":"pre","contentObject":[{"type":"text","content":"\n ","gated":false}],"gated":false},{"type":"text","content":"\n","gated":false},{"type":"p","contentObject":[{"type":"text","content":"\n  (END) Dow Jones Newswires","gated":false}],"gated":false},{"type":"text","content":"\n","gated":false},{"type":"p","contentObject":[{"type":"text","content":"\n  10-18-21 0414ET","gated":false}],"gated":false},{"type":"text","content":"\n\nCopyright (c) 2021 Dow Jones & Company, Inc.","gated":false}]}